| Mrs Elisabeth Meehna Hernandez, MSN RN APRN-CNS CCM | |
|
2677 Willakenzie Rd Ste 2, Eugene, OR 97401-4873 | |
| (708) 666-0030 | |
| Not Available |
| Full Name | Mrs Elisabeth Meehna Hernandez |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Acute Care |
| Location | 2677 Willakenzie Rd Ste 2, Eugene, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871222430 | NPI | - | NPPES |
| 202213113CNS-PP | Other | OR | APRN LICENSE |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Elisabeth Meehna Hernandez, MSN RN APRN-CNS CCM 2555 Garfield St, Eugene, OR 97405-1667 Ph: (708) 666-0030 | Mrs Elisabeth Meehna Hernandez, MSN RN APRN-CNS CCM 2677 Willakenzie Rd Ste 2, Eugene, OR 97401-4873 Ph: (708) 666-0030 |
News Archive
It's Valentine's Day, he forgot to bring flowers, and somehow that painfully sad look on her face is simply not registering in his mind. Could be it's a problem in his prefrontal cortex? Neuropsychology researchers at the Montreal Neurological Institute and Hospital - The Neuro, McGill University, have found that two areas of the prefrontal cortex (PFC) are critical for either detecting or distinguishing emotions from facial expressions.
The journal of AIDS Research and Human Retroviruses has published a special issue examining the "complex factors involved in the sexual transmission of HIV, the urgent need for new preventive approaches, and the most promising methods currently in development," according to a press release from the publisher, Mary Ann Leibert, Inc.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today signed a Business Cooperation Agreement with South Korea-based Celltrion, Inc. and Celltrion Healthcare, Inc. ("Celltrion"), which outlines the business terms of a future distribution agreement for the United States, Europe, Australia, New Zealand and Canada for eight biogeneric products that are currently under development by Celltrion, five of which are incremental to Hospira's pipeline.
PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, today announced Phase I clinical trial results for Protexia, a pegylated recombinant version of human butyrylcholinesterase (rBChE), which has been shown to be effective in animal models in preventing toxicity from exposure to chemical nerve agents.
WHO's first release of surveillance data on antibiotic resistance reveals high levels of resistance to a number of serious bacterial infections in both high- and low-income countries.
› Verified 4 days ago
Dr. Deborah A Phillips, PHD, ARNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 66 Club Rd Ste 160, Eugene, OR 97401 Phone: 541-345-1722 Fax: 541-485-7049 | |
Claudia Fischer, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 2027 Jefferson St., Eugene, OR 97405 Phone: 541-729-1090 | |
Xinyang Xu, GNP Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 4010 Aerial Way, Eugene, OR 97402 Phone: 541-242-8300 | |
Dr. Wendy Hill Park, PHD, CNS-PP ,BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 207 E 5th Ave Ste 246, Eugene, OR 97401 Phone: 541-200-6899 Fax: 541-460-5167 | |
Ms. Lee Ann Hawkins, APRN, BC Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 1255 Pearl St, Eugene, OR 97401 Phone: 541-687-6983 |